Ojaghihaghighi S, Vahdati SS, Mikaeilpour A, Ramouz A. Comparison of neurological clinical manifestation in patients with hemorrhagic and ischemic stroke. World J Emerg Med 2017;8(1):34–38. DOI: 10.5847/wjem.j.1920-8642.2017.01.006.
Chen S, Zeng L, Hu Z. Progressing haemorrhagic stroke: Categories, causes, mechanisms and managements. J Neurol 2014;261(11): 2061–2078. DOI: 10.1007/s00415-014-7291-1.
Al-Alawi AKA, Hazra D, Al-Hassani MJK, Al-Jamoudi ASA. Unveiling the crystal ball: Predictors of adverse outcomes in intracerebral hemorrhage patients. Indian J Crit Care Med 2023;27(12):895–901.
Song L, Hu X, Ma L, Chen X, Ouyang M, Billot L, et al. INTEnsive care bundle with blood pressure reduction in acute cerebral hemorrhage trial (INTERACT3): Study protocol for a pragmatic stepped-wedge cluster-randomized controlled trial. Trials 2021;22(1):943. DOI: 10.1186/s13063-021-05881-7.
Dickmann U, Voth E, Schicha H, Henze T, Prange H, Emrich D. Heparin therapy, deep-vein thrombosis and pulmonary embolism after intracerebral hemorrhage. Klin Wochenschr 1988;66(23):1182–1183. DOI: 10.1007/BF01727666.
Boeer A, Voth E, Henze T, Prange HW. Early heparin therapy in patients with spontaneous intracerebral haemorrhage. J Neurol Neurosurg Psychiatry 1991;54(5):466–467. DOI: 10.1136/jnnp.54.5.466.
Kleindienst A, Harvey HB, Mater E, Bronst J, Flack J, Herenz K, et al. Early antithrombotic prophylaxis with low molecular weight heparin in neurosurgery. Acta Neurochir (Wien) 2003;145(12):1085–1090; discussion 1090–1091. DOI: 10.1007/s00701-003-0142-y.
Kiphuth IC, Staykov D, Köhrmann M, Struffert T, Richter G, Bardutzky J, et al. Early administration of low molecular weight heparin after spontaneous intracerebral hemorrhage. A safety analysis. Cerebrovasc Dis 2009;27(2):146–150. DOI: 10.1159/000177923.
Paciaroni M, Agnelli G, Venti M, Alberti A, Acciarresi M, Caso V. Efficacy and safety of anticoagulants in the prevention of venous thromboembolism in patients with acute cerebral hemorrhage: A meta-analysis of controlled studies. J Thromb Haemost 2011;9(5):893–898. DOI: 10.1111/j.1538-7836.2011.04241.x.
Moradiya Y, Murthy SB, Newman-Toker DE, Hanley DF, Ziai WC. Intraventricular thrombolysis in intracerebral hemorrhage requiring ventriculostomy: A decade-long real-world experience. Stroke 2014;45(9):2629–2635. DOI: 10.1161/STROKEAHA.114.006067.
Masotti L, Godoy DA, Di Napoli M, Rabinstein AA, Paciaroni M, Ageno W. Pharmacological prophylaxis of venous thromboembolism during acute phase of spontaneous intracerebral hemorrhage: What do we know about risks and benefits? Clin Appl Thromb Hemost 2012;18(4):393–402. DOI: 10.1177/1076029612441055.
Woo D, Comeau ME, Venema SU, Anderson CD, Flaherty M, Testai F, et al. Risk factors associated with mortality and neurologic disability after intracerebral hemorrhage in a racially and ethnically diverse cohort. JAMA Netw Open 2022;5(3):e221103. DOI: 10.1001/jamanetworkopen.2022.1103.
Fernando SM, Qureshi D, Talarico R, Tanuseputro P, Dowlatshahi D, Sood MM, et al. Intracerebral hemorrhage incidence, mortality, and association with oral anticoagulation use: A population study. Stroke 2021;52(5):1673–1681. DOI: 10.1161/STROKEAHA.120.032550.
